Remarkably enhanced inhibitory effects of three-component hybrid liposomes including sugar surfactants on the growth of lung carcinoma cells

被引:5
作者
Ueoka, R
Matsumoto, Y
Hirose, S
Goto, K
Goto, M
Furusaki, S
机构
[1] Sojo Univ, Grad Course Appl Chem, Kumamoto 8600082, Japan
[2] Kyushu Univ, Dept Appl Chem, Higashi Ku, Class Mol Syst Engn, Fukuoka 8128581, Japan
关键词
liposome; sugar surfactant; antitumor;
D O I
10.1248/cpb.50.563
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Sugar parts play important roles in recognizing molecules on the cell membranes. We successfully produced sugar-type micellar surfactants, lactonoalkylamide (LacC(n)), for the first time. Spherical vesicles, three-component hybrid liposomes, were obtained after the sonication of the mixture of L-alpha-dimyristoylphosphatidyleholine (DMPC), Tween 20 and LacC(n) (DMPC: Tween 20:LacC(n)=65:7:28). It is noteworthy that high inhibitory effects of the three-component hybrid liposomes composed of DMPC, Tween 20, and LacC(n) (DMPC: Tween 20: LacC(n)=65: 7: 28) on the growth of glioma (U251) and lung adenocarcinoma (RERF-LC-OK) cells were attained in vitro without any drug, although no significant inhibitory effects of any individual component (DMPC, Tween 20, LacC(n)) or the two-component hybrid liposomes of DMPC and Tween 20 on the growth of tumor cells examined were obtained.
引用
收藏
页码:563 / 565
页数:3
相关论文
共 17 条
[1]  
GABIUS HJ, 1987, ANTICANCER RES, V7, P109
[2]  
ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P118
[3]  
Kanno A., 1998, DRUG DELIVERY SYSTEM, V13, P101
[4]  
Kanno A, 1999, DRUG DELIVERY SYSTEM, V14, P37
[5]  
Kitamura I, 1996, CANCER RES, V56, P3986
[6]  
KOBAYASHI K, 1994, YUKAGAKU, V43, P960
[7]  
LASIC DD, 1993, LIPOSOMES PHYSICS AP, P261
[8]  
Matsumoto Y, 1999, CHEM LETT, P53
[9]   Highly specific inhibitory effect of three-component hybrid liposomes including sugar surfactants on the growth of glioma cells [J].
Matsumoto, Y ;
Kato, T ;
Suzuki, H ;
Hirose, S ;
Naiki, Y ;
Hirashima, M ;
Ueoka, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (23) :2617-2619
[10]  
MATSUMOTO Y, 1995, BIOL PHARM BULL, V18, P1456